| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977756 | Brachytherapy | 2012 | 5 Pages |
Abstract
This retrospective series suggests that interstitial perineal HDRB is a safe and effective treatment option for primary or locally recurrent gynecological malignancies. It is a valuable option in patients who have received previous EBRT to the pelvis, achieving good local control with acceptable late treatment-related side effects.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Paulo B. De Ieso, Vinod Mullassery, Raj Shrimali, Gerry Lowe, Linda Bryant, Peter J. Hoskin,